|Articles|May 2, 2015
Jasmine Martin Discusses Oral Adherence
Author(s)Jasmine Martin
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
Advertisement
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
“If patients aren’t taking their drugs, then how do we know that the outcomes will be [the same as] what the clinical trial [outcomes] were?” Martin asks.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Taking Back the Razor: Choosing Power in the Face of Hair Loss
2
The Cost of the Unicorn: Why Pancreatic Cancer Survival Isn't a Marathon
3
The Current Treatment Landscape in Multiple Myeloma
4
Tukysa May Be ‘Patient Friendly’ Frontline Maintenance Option in HER2+ Breast Cancer
5